Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

386
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
386
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

694
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
694
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

337
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
337

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between a Periconception Healthy Plant-Based Diet and Adverse Pregnancy Outcomes.

The Journal of nutrition·2026
Same author

Strengthening community-based doula and clinician partnerships through implementation and dissemination science approaches: a mixed-methods pilot study.

Implementation science communications·2026
Same author

Insights from U.S. Women on Navigating Dietary Recommendations for Gestational Diabetes Mellitus: A Qualitative Interview Study.

American journal of perinatology·2026
Same author

The Association Between Periconceptional Consumption of Ultra-Processed Food and the Incidence of Adverse Pregnancy Outcomes.

Nutrients·2026
Same author

Exploring the Lived Experience of Healthcare Discrimination and Resilience among Postpartum African American Women: A Qualitative Study.

Journal of racial and ethnic health disparities·2026
Same author

Interoception and eating behavior in participants at risk for hypertensive disorders of pregnancy.

Journal of complementary & integrative medicine·2025

Related Experiment Video

Updated: Sep 12, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K

Current Practices in Gestational Diabetes.

Anna Palatnik1, Maisa N Feghali2

  • 1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Medical College of Wisconsin, Cardiovascular Center, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.

Obstetrics and Gynecology Clinics of North America
|August 6, 2025
PubMed
Summary

Optimal gestational diabetes mellitus (GDM) treatment requires clear targets and adherence support. Insulin is preferred, but individualized strategies are crucial for maternal and child health given rising GDM prevalence.

Keywords:
Gestational diabetesIncretinsInsulinMedical nutrition therapyMetforminPharmacologic treatment

More Related Videos

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

763
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

69.4K

Related Experiment Videos

Last Updated: Sep 12, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K
Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

763
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

69.4K

Area of Science:

  • Obstetrics and Gynecology
  • Endocrinology
  • Public Health

Background:

  • Gestational diabetes mellitus (GDM) poses significant maternal and fetal risks.
  • Current GDM management faces challenges in defining optimal glycemic targets and treatment thresholds.
  • Adherence to lifestyle interventions like medical nutrition therapy and exercise is often limited by practical and psychological factors.

Purpose of the Study:

  • To review current challenges and best practices in gestational diabetes mellitus management.
  • To highlight the need for individualized treatment strategies and effective pharmacotherapy.
  • To emphasize the importance of improving maternal health and long-term child outcomes in the context of rising GDM prevalence.

Main Methods:

  • Literature review of current GDM guidelines and research.
  • Analysis of pharmacotherapy options, focusing on insulin efficacy and safety.
  • Discussion of adherence barriers to medical nutrition therapy and exercise.

Main Results:

  • Gaps persist in defining precise glycemic targets and pharmacotherapy initiation points for GDM.
  • Individualized support and structured guidance are key to improving adherence to lifestyle modifications.
  • Insulin remains the preferred pharmacologic agent due to its safety and effectiveness profile.

Conclusions:

  • Optimizing GDM management necessitates addressing adherence challenges and refining treatment thresholds.
  • Personalized medical nutrition therapy, exercise, and pharmacotherapy are essential for improved maternal and fetal outcomes.
  • Novel therapeutic approaches are urgently needed to combat the increasing incidence of GDM and its long-term health implications.